⌘K
OverviewStock screenerAnalyst actionsTicker roomsCalendar
MarketsInvestorsSign in
StockSwitzerlandNYSE

NVS

Novartis AG

Healthcare · Drug Manufacturers - General

151.12USD

-5.1500 (-3.30%)

Alert
DescriptionHistoricalFinancialsRelative ValueResearchNewsCommunityRoomOptionsPrice Chart ↗Fundamental Chart ↗
ProfileRatiosRevenue & EPS
Reading financial statements from SEC filings…
A first visit to a security takes a few seconds.

Community sentiment

Not enough data yet

A reading needs 5 members, each at least 14 days old with a track record on this site (simulated portfolios and calls), who shared a take in the last 30 days; 2 of them need a strong record.

Sign in to share your take on NVS.

Members' own stated views, weighted by account age and track record on this site (simulated portfolios and calls). Not a forecast or a price signal. How this is worked out
  • Only members whose accounts are at least 14 days old and who have a track record on this site (simulated portfolios and calls) count, and bots never do. A take from anyone else is saved and starts to count the day they qualify.
  • A take fades: it counts half as much after 7 days and drops out after 30.
  • Members with a strong record count more. Everyone else counts together for a capped share, so many accounts cannot outweigh a few strong ones.
  • Nothing is shown until 5 qualifying members have taken part, 2 of them with a strong record. It stays an early read until 3 have one and the sample is large enough.
  • Until 20 members have taken part the marker only says bullish, bearish or mixed, at a fixed spot, and the number of members is given as a band, not a count.
  • The reading is refreshed about every 30 minutes, so a take you have just made will not move it straight away.
  • Your own take is private: only the totals are shown, and never who said what.
Fiscal Year End12/2025
Last Quarter End06/2026 Q2
Current/T12M(USD)
1)

Issue Data

Last PxUSD / 151.12
P/E22.5
Dvd Ind Yld3.1%
P/B6.91
P/S5.1
Curr EV/T12M EBITDA14.5
Mkt Cap (USD)287.2B
Curr EV (USD)329.0B
2)

Per Share Data

EPS T12M6.63
DPS8.82
Bk Val Per Sh21.86
Rev/Sh29.62
Cash/Sh4.01
Curr Shares Out1,900.7M
FCF/Sh7.83
3)

Cash Flow Analysis

P/CF15.6
Curr P/FCF19.2
CF/NI1.4
Dvd P/O132.4%
Cash Gen/Cash Reqd0.9
Csh Dvd Cov1.1
CFO/Sales32.4%
Eff Interest Rate3.6%
4)

Growth Potential

Dil EPS 1Y Gr21.8%
Cap 1Y Gr8.3%
BPS 1Y Gr9.0%
R&D To Sales20.6%
Retention Rate-32.4%
Rev 1Y Gr9.6%
FCF 1Y Gr10.4%
Assets 1Y Gr8.5%
5)

Profitability

EBITDA22.6B
EBIT17.1B
Operating Margin30.2%
Pretax Margin27.4%
Net Margin22.5%
ROA11.3%
ROE30.5%
ROC15.8%
Asset Turnover0.50
6)

Structure

Current Ratio0.86
Quick Ratio0.55
Debt/Assets38.6%
Debt/Com Eq113.3%
Net Debt/EBITDA1.74
Tot Debt/Capital53.1%
Gross Margin74.7%
EBIT/Int Exp12.3

Returns and turnover use the AVERAGE balance over the year, not the closing snapshot. Growth rates compare the two most recent fiscal years.